ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4.62 Cr | ₹4.52 Cr | ₹1.96 Cr | ₹1.63 Cr | ₹4.03 Cr |
What is the latest Contingent Liabilities ratio of ALBERT DAVID ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹4.62 Cr |
| Mar2024 | ₹4.52 Cr |
| Mar2023 | ₹1.96 Cr |
| Mar2022 | ₹1.63 Cr |
| Mar2021 | ₹4.03 Cr |
How is Contingent Liabilities of ALBERT DAVID Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.62 Cr | 2.17 | |
| Mar2024 | ₹4.52 Cr | 130.38 | |
| Mar2023 | ₹1.96 Cr | 20.22 | |
| Mar2022 | ₹1.63 Cr | -59.46 | |
| Mar2021 | ₹4.03 Cr | - | |
Compare Contingent Liabilities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹392.4 Cr | -5.9% | -8.2% | -39.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,773.0 Cr | -3.6% | -6.8% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,540.0 Cr | -5.4% | -2.4% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,529.0 Cr | 3.6% | 8.5% | 23.5% | Stock Analytics | |
| CIPLA | ₹111,299.0 Cr | -5.1% | -7.1% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,393.0 Cr | -4.1% | -8.3% | -12.1% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | -5.9% |
-8.2% |
-39.5% |
| SENSEX | -2% |
-2.8% |
7.4% |
You may also like the below Video Courses